Skip to main content
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Product identification

Medicine name:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte, 458.4+125+20mg/ml, Injekční roztok
Active substance:
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate
Target species:
  • Horse
  • Cattle
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • CALCIUM GLUCONATE FOR INJECTION
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium glycerophosphate pentahydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Cattle
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:
  • Polypropylene (PP) bottles closed with a bromobutyl rubber stopper, type I and secured with an aluminium cap. Package size: 500 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/003/22-C
Date of authorisation status change:
Reference member state:
  • Poland
Procedure number:
  • PL/V/0110/002
Concerned member states:
  • Bulgaria
  • Czechia
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Portugal
  • Romania
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."